Safety and short-term efficacy of adjuvant nivolumab after neoadjuvant docetaxel, cisplatin, and fluorouracil for locally advanced esophageal squamous cell carcinoma.

被引：0
|
作者：
Okunaka, Mashiro
Kotani, Daisuke
Sato, Kazuma
Fujiwara, Naoto
Mishima, Saori
Shitara, Kohei
Fujita, Takeo
Kojima, Takashi
机构：
[1] Natl Canc Ctr Hosp East, Dept Pharm, Kashiwa, Japan
[2] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Japan
[3] Natl Canc Ctr Hosp East, Div Esophageal Surg, Kashiwa, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
261-3278; 613-4678-146; 281-318-430; 261-492-2769; 283-424-6846-271-2644; 613-135-244-3829-325; 613-135-2370-7650-2454; 7; 5; 4; 3; 14; 154; 54; 256; 3592; 8; 1;
D O I：
10.1200/JCO.2024.42.3_suppl.271
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：271 / 271
页数：1
相关论文
共 50 条
  • [1] Short-term safety of adjuvant nivolumab therapy after neoadjuvant docetaxel plus cisplatin and 5-FU therapy for locally advanced esophageal squamous cell carcinoma.
    Hirose, Toshiharu
    Yamamoto, Shun
    Kadono, Toru
    Ikeda, Go
    Ohara, Akihiro
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Ishiyama, Koshiro
    Oguma, Junya
    Daiko, Hiroyuki
    Kato, Ken
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 312 - 312
  • [2] The overall safety and short-term efficacy of nivolumab plus ipilimumab for advanced esophageal squamous cell carcinoma.
    Shiraishi, Kazuhiro
    Yamamoto, Shun
    Yoshinami, Yuri
    Ohara, Akihiro
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Kashiraha, Tairo
    Kurita, Daisuke
    Ishiyama, Koshiro
    Oguma, Junya
    Igaki, Hiroshi
    Daiko, Hiroyuki
    Kato, Ken
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 329 - 329
  • [3] Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable locally advanced esophageal squamous cell carcinoma
    Yoshinami, Y.
    Yamamoto, S.
    Shiraishi, K.
    Itoyama, M.
    Imazeki, H.
    Yokoyama, K.
    Honma, Y.
    Kurita, D.
    Ishiyama, K.
    Oguma, J.
    Daiko, H.
    Kato, K.
    [J]. ANNALS OF ONCOLOGY, 2024, 35 : S168 - S168
  • [4] Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma.
    Yoshinami, Yuri
    Yamamoto, Shun
    Kadono, Toru
    Hirose, Toshiharu
    Ikeda, Go
    Ohara, Akihiro
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Ishiyama, Koshiro
    Oguma, Junya
    Daiko, Hiroyuki
    Kato, Ken
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 373 - 373
  • [5] Short-term Outcomes of Adjuvant Nivolumab After Neoadjuvant Chemotherapy in Patients With Resected Esophageal Squamous Cell Carcinoma
    Sugase, Takahito
    Kanemura, Takashi
    Takeoka, Tomohira
    Matsuura, Norihiro
    Masuike, Yasunori
    Shinno, Naoki
    Hara, Hisashi
    Kitakaze, Masatoshi
    Kubo, Masahiko
    Mukai, Yosuke
    Sueda, Toshinori
    Hasegawa, Shinichiro
    Akita, Hirofumi
    Nishimura, Junichi
    Wada, Hiroshi
    Yasui, Masayoshi
    Omori, Takeshi
    Miyata, Hiroshi
    [J]. ANTICANCER RESEARCH, 2024, 44 (01) : 185 - 193
  • [6] Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) for locally advanced esophageal squamous cell carcinoma
    Sasaki, Ken
    Uchikado, Yasuto
    Omoto, Itaru
    Arigami, Takaaki
    Osako, Yusaku
    Noda, Masahiro
    Okumura, Hiroshi
    Maemura, Kosei
    Higashi, Ryutaro
    Yoshiura, Takashi
    Natsugoe, Shoji
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (03) : 581 - 587
  • [7] Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) for locally advanced esophageal squamous cell carcinoma
    Ken Sasaki
    Yasuto Uchikado
    Itaru Omoto
    Takaaki Arigami
    Yusaku Osako
    Masahiro Noda
    Hiroshi Okumura
    Kosei Maemura
    Ryutaro Higashi
    Takashi Yoshiura
    Shoji Natsugoe
    [J]. Cancer Chemotherapy and Pharmacology, 2019, 83 : 581 - 587
  • [8] The efficacy and safety of neoadjuvant sintilimab combined with chemotherapy in elderly patients with locally advanced esophageal squamous cell carcinoma.
    Lv, Huilai
    Huang, Chao
    Li, Jiachen
    Zhang, Fan
    Gai, Chunyue
    Liu, Zhao
    Xu, Shi
    Wang, Mingbo
    Li, Zhenhua
    Tian, Ziqiang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 378 - 378
  • [9] Adjuvant docetaxel, cisplatin and 5-Fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck
    Baghi, M
    Hambek, M
    May, A
    Radeloff, A
    Gstoettner, W
    Knecht, R
    [J]. ANTICANCER RESEARCH, 2006, 26 (1B) : 559 - 563
  • [10] Short-term outcomes of induction chemotherapy with docetaxel, cisplatin, and fluorouracil (TPF) in locally advanced nasopharyngeal carcinoma
    Takamizawa, Shigemasa
    Honma, Yoshitaka
    Murakami, Naoya
    Mori, Taisuke
    Oka, Hiroki
    Yamamoto, Shun
    Kashihara, Tairo
    Ito, Kimiteru
    Kubo, Yuko
    Ikeda, Atsuo
    Matsumoto, Fumihiko
    Omura, Go
    Kobayashi, Kenya
    Itami, Jun
    Kato, Ken
    Yoshimoto, Seiichi
    [J]. INVESTIGATIONAL NEW DRUGS, 2021, 39 (02) : 564 - 570
12345